CNOT8 Activators
CNOT8 Activators are a group of chemical compounds that facilitate the enhancement of the CNOT8 protein's functional role in mRNA degradation. Compounds such as Forskolin and Rolipram act to increase intracellular levels of cAMP, with the former directly activating adenylate cyclase and the latter inhibiting phosphodiesterase 4, thereby sustaining cAMP levels. Elevated cAMP enhances CNOT8 activity by promoting pathways involved in mRNA decay, crucial for the regulation of gene expression. A-769662, through the activation of AMPK, and Ionomycin, by increasing intracellular calcium, may also contribute to the regulation of mRNA turnover, potentially modulating CNOT8's activity. Trichostatin A, with its effect on chromatin remodeling, may indirectly impact CNOT8 by affecting RNA substrates' accessibility, while LY294002 and U0126 target PI3K and MEK, respectively, influencing downstream pathways that could intersect with the functional mechanisms of CNOT8.
Further contributing to the dynamic modulation of CNOT8 are chemicals that perturb cellular energy balance and stress responses. 2-Deoxy-D-glucose inhibits glycolysis, thereby possibly elevating CNOT8 function by linking energy status to mRNA degradation. Rapamycin, as an mTOR inhibitor, may enhance CNOT8's role by adjusting the translation and stability of mRNAs, interconnected with CNOT8-mediated decay. Similarly, SB203580's inhibition of p38 MAPK and ZM-447439's suppression of Aurora kinases could shift cellular signaling equilibria, favorably positioning CNOT8 to execute its role in mRNA deadenylation and degradation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which in turn can enhance CNOT8 activity by promoting mRNA degradation through cAMP-responsive pathways. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram, a selective phosphodiesterase 4 inhibitor, prevents cAMP breakdown, potentially enhancing CNOT8's role in mRNA deadenylation and decay by sustaining elevated cAMP levels. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A-769662 activates AMP-activated protein kinase (AMPK), which could indirectly enhance CNOT8 activity as part of cellular energy balance, influencing mRNA turnover processes. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that elevates intracellular calcium levels, potentially modulating CNOT8 activity through calcium-sensitive signaling pathways affecting mRNA stability. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, can alter chromatin structure and thus indirectly affect the functional activity of CNOT8 by changing the availability of RNAs for degradation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that could indirectly enhance CNOT8 activity by altering signaling cascades that impact mRNA stability and degradation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine inhibits DNA methyltransferases, which may influence CNOT8 activity indirectly by affecting the pool of mRNAs available for degradation. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
2-Deoxy-D-glucose is a glycolysis inhibitor that can indirectly increase CNOT8 activity by affecting cellular energy status and thereby potentially influencing the mRNA degradation pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which could lead to enhanced CNOT8 activity due to the role of mTOR in regulating mRNA stability and translation, processes closely linked with mRNA degradation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that may enhance CNOT8 activity by modulating signaling pathways that affect mRNA decay mechanisms. | ||||||